NetworkNewsBreaks – CytoDyn Inc. (CYDY) President and CEO Featured in Uptick Newswire’s Stock Day Podcast

Biotechnology company CytoDyn (OTCQB: CYDY) this morning announced the featured interview of its President and CEO Nader Z. Pourhassan, Ph.D. with Stock Day’s Everett Jolly. Jolly initiated the discussion by asking about CytoDyn’s PRO 140. The company’s flagship product is a humanized IgG4 monoclonal antibody that is designed to bind to cellular receptor CCR5, which plays various roles with implications in HIV, tumor metastasis and immune signaling. Pending FDA approval, which the company hopes to secure in Q4 2019, Pourhassan indicates that PRO 140 may be available to the public in 2020.  “Most biotech companies, when they finish the biologic application, they have an 85% chance to get approved. 9 out of 10 who don’t get approved is because of the safety of the product. Our product has received fast track designation due to having great safety among all of the approved drugs,” Nader Z. Pourhassan, Ph.D., president and CEO of CytoDyn, stated in the news release.

To hear the Stock Day Podcast featuring the interview, visit http://nnw.fm/kYJU8

To view the full press release, visit http://nnw.fm/4Q7xo

About CytoDyn

CytoDyn is a biotechnology company developing innovative treatments for multiple therapeutic indications based on PRO 140 (leronlimab), a novel humanized monoclonal antibody targeting the CCR5 receptor. CCR5 plays a key role in the ability of HIV to enter and infect healthy T-cells.  The CCR5 receptor is also implicated in tumor metastasis and in immune-mediated illnesses such as graft-vs-host disease (GvHD) and NASH. CytoDyn has successfully completed a Phase 3 pivotal trial with PRO 140 in combination with standard anti-retroviral therapies in HIV-infected treatment-experienced patients. The Company plans to seek FDA approval for PRO 140 in combination therapy and plans to complete the filing of a Biological License Application (BLA) in the first quarter of 2019 for that indication. CytoDyn is also conducting a Phase 3 investigative trial with PRO 140 as a once-weekly monotherapy for HIV-infected patients, and plans to initiate a registration-directed study of PRO 140 monotherapy indication, which if successful, could support a label extension. Clinical results to date from multiple trials have shown that PRO 140 can significantly reduce viral burden in people infected with HIV with no reported drug-related serious adverse events (SAEs). Moreover, results from a Phase 2b clinical trial demonstrated that PRO 140 monotherapy can prevent viral escape in HIV-infected patients, with some patients on PRO 140 monotherapy remaining virally suppressed for more than four years. CytoDyn is also conducting a Phase 2 trial to evaluate PRO 140 for the prevention of GvHD and expects to initiate clinical trials with PRO 140 in metastatic triple-negative breast cancer in 2018. For more information, visit the company’s website at www.CytoDyn.com

More from NetworkNewsBreaks

NetworkNewsBreaks – Net Element, Inc. (NASDAQ: NETE) Launches Comprehensive POS Solution, Aptito NetworkNewsBreaks – Foresight Autonomous Holdings Ltd.’s (NASDAQ: FRSX) (TASE: FRSX) QuadSight Wins 2019 CES Innovation Award NetworkNewsBreaks – Plus Products Inc. (CSE: PLUS) Brings to Market its Cranberry & Shortbread Gummies: 2018 Holiday Limited Edition

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire has received compensation from CytoDyn Inc. for providing certain investor relations, marketing and social media services, including the preparation of this report, and expects to receive additional compensation for such services in the future. This compensation includes a monthly program fee.

Latest News

Myanmar by-elections a test for Suu Kyi's ruling party

Nov 18, 2018

YANGON, Myanmar — Voters in several parts of Myanmar went to the polls Saturday in 13 by-elections seen as a test of support for leader Aung San Suu Kyi and her ruling party. Suu Kyi's National League for Democracy won a landslide victory in the 2015 general election, putting an end to decades of rule by the military and its proxies, though the army retains considerable power under a constitution it implemented. Suu Kyi's appeal with the country's Buddhist majority has not suffered much from a crisis involving 700,000 members of the Muslim Rohingya minority who fled a brutal army...

Aussie nun who angered Duterte forced to leave Philippines

Nov 18, 2018

MANILA, Philippines — An Australian nun who angered the Philippine president by joining anti-government protests has called on Filipinos to unite and fight human rights abuses ahead of her forced departure from the country. Sister Patricia Anne Fox is set to leave the Philippines on Saturday for Australia after the Bureau of Immigration ordered her deported months ago and downgraded her missionary visa to a temporary visitor's visa, which expires Saturday. During a farewell news conference Saturday, the 71-year-old Fox called on Filipinos to speak up and help the marginalized fight to gain land, houses and jobs. She told The...

UN finds 486 million in Asia still hungry, progress stalled

Nov 18, 2018

BANGKOK — A United Nations report says some 486 million people are malnourished in Asia and the Pacific and progress in alleviating hunger is stalling. The report by the Food and Agricultural Organization released Friday said more than half of all children in the world who are malnourished live in the region. It says hunger-related stunting that causes permanent damage is being worsened by food insecurity and inadequate sanitation, even in big cities in relatively affluent countries. It says the main reason people still go hungry is poverty and unequal access to good food, clean water and toilets. Many who...

Indonesian airline whose plane crashed a low-cost high flyer

Nov 18, 2018

BANGKOK — Lion Air, the airline whose plane crashed early Monday while traveling from Jakarta to an island off Indonesia's Sumatra with 189 people on board, is a fast-growing low cost airline with a mixed safety record. The privately-owned carrier was founded in 1999 to provide access to air travel to everyone. It offers dozens of flights a day both internationally and within the archipelago's more than 17,000 islands. The biggest airline in the country in terms of passenger numbers and one of the largest low-cost carriers after Malaysia-based AirAsia, it mostly flies Boeing 737s. Before Monday's crash the airline...

Former No. 1 Wozniacki has rheumatoid arthritis

Nov 18, 2018

SINGAPORE — Caroline Wozniacki was diagnosed with rheumatoid arthritis before the U.S. Open, the Danish tennis player revealed at the WTA Finals on Thursday. She made the announcement after being eliminated from the year-end competition following a 5-7, 7-5, 6-3 loss to Elina Svitolina in her third round-robin match. "It turns out that I have an autoimmune disease, rheumatoid arthritis, which goes in and attacks your joints," she said. "When the body has a lot of fluids in it and you swell up, you get tired, you get exhausted, all these things. "In the beginning, it was a shock. You...

Sign up now!